Abstract

Get full access to this article
View all access options for this article.
References
1.
Altman D G
(1992 ) Confidence intervals in research evaluation . Annal Int Med
116 (Suppl 2 ): A28
2.
Altman D G
,
Bland J M
(1999 ) Statistics notes. Treatment allocation in controlled trials: why randomise?
Br Med J
318 : 1209
3.
Carney S M
,
Geddes J R
(2002 ). Systematic Reviews and meta-analyses in evidence in mental health care , pp. 72 -80 . Brunner Routledge , Hove
4.
Cochrane Collaboration
(1995 ) Cochrane collaboration handbook (updated July 1995). Cochrane , Oxford
5.
Geddes J R
,
Wilczynski N
,
Reynolds S
,
Szatmari P
,
Streiner D L
(1999 ) Evidence-based mental health - the first year . Evidence-Based Mental Health
2 : 3 -5
6.
Geddes J R
,
Freemantle N
,
Harrison P J
,
Bebbington P E
(2000 ) Atypical antipsychotics in the treatment of schizophrenia: systematic review and meta-regression analysis . Br Med J
321 : 1371 -1376
7.
Irwig L
,
Tosteson A N
,
Gatsonis C
,
Lau J
,
Colditz G
,
Chalmers T C
,
Mosteller F
(1994 ) Guidelines for meta-analyses evaluating diagnostic tests . Annal Int Med
120 : 667 -676
8.
Mulrow C D
(1987 ). The medical review article: state of the science . Annal Int Med
106 : 485 -488
9.
Stroup D F
,
Berlin J A
,
Morton S C
,
Olkin I
,
Williamson G D
,
Rennie D
,
Moher D
,
Becker B J
,
Sipe T A
,
Thacker S B
(2000 ) Meta-analysis of observational studies in Epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group . JAMA
283 : 2008 -2012
10.
Thompson S G
(1994 ) Why sources of heterogeneity in meta-analysis should be investigated . Br Med J
309 : 1351 -1355
